Difference between revisions of "C-Fos-Cre DREADD"
Jump to navigation
Jump to search
m (→Fos-Cre) |
(added some overview figures) |
||
Line 1: | Line 1: | ||
+ | == Overview == | ||
+ | |||
+ | <gallery mode="traditional" widths=300px heights=300px> | ||
+ | Fos-Cre-DREADD-schema.png|Chemogenetic expression of DREADD receptors in c-Fos-positive cells after stimulation | ||
+ | Excitatory-DREADD-schema.png|Schematic timeline of recapitulating stimulation with excitatory DREADDs | ||
+ | Inhibitory-DREADD-schema.png|Schematic timeline of attenuating stimulation with inhibitory DREADDs | ||
+ | </gallery> | ||
+ | |||
== Mouse Strains == | == Mouse Strains == |
Revision as of 10:03, 12 August 2020
Overview
Mouse Strains
Fos-CreER
Fos-tm2.1(icre/ERT2)Luo (JAX 030323)
hM3Dq
B6N;129-Tg(CAG-CHRM3*,-mCitrine)1Ute/J, aka CAG-LSL-Gq-DREADD (JAX 026220)
hM4Di
B6N.129-Gt(ROSA)26Sortm1(CAG-CHRM4*,-mCitrine)Ute/J, aka R26-LSL-Gi-DREADD (JAX 026219)
Reagents
(Z)-4-Hydroxytamoxifen , Sigma-Aldrich H7904-5MG
Clozapine N-oxide (CNO) . APExBIO A3317 10mg
DMSO USP, Spectrum Chemical D1258-100ML
Sesame Oil, NF Spectrum Chemical SE130-500MLGL